A review of reported stakeholder engagement in early-stage translational research.

IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Journal of Clinical and Translational Science Pub Date : 2024-11-18 eCollection Date: 2025-01-01 DOI:10.1017/cts.2024.620
Thomas W Concannon, Marguerite Fenwood Hughes, Amy E LaVertu, Jonathan Garlick, Alice M Rushforth
{"title":"A review of reported stakeholder engagement in early-stage translational research.","authors":"Thomas W Concannon, Marguerite Fenwood Hughes, Amy E LaVertu, Jonathan Garlick, Alice M Rushforth","doi":"10.1017/cts.2024.620","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We conducted a scoping review of peer-reviewed literature to describe the nature and extent of reporting on the involvement of stakeholders in early-stage translational research.</p><p><strong>Methods and results: </strong>We conducted two literature searches in six databases, screened records and full-text articles, and abstracted and analyzed data from included publications. The literature searches yielded unduplicated 2,894 records. After screening, 13 articles were included.</p><p><strong>Findings: </strong>Our review of the literature yielded rare reports of engagement in early-stage translational research. Half of included articles reported on engagement with patients, clinicians, and researchers while fewer that one in three reported on engagement with policymakers, industry, and insurers. One in four reported engagement in the publication's acknowledgments but not in the main text. More than half drew unmeasured conclusions about the outcomes of engagement.</p><p><strong>Interpretation: </strong>Our definition of early-stage translation pointed to a specific set of peer-reviewed research; our findings indicate a reporting gap and not necessarily a gap in practice. By addressing four themes-developing a shared language, identifying frameworks and principles, creating a repository of resources, and establishing a research agenda, research leaders can develop new insights about how to engage communities in early-stage translational research.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e24"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795857/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/cts.2024.620","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We conducted a scoping review of peer-reviewed literature to describe the nature and extent of reporting on the involvement of stakeholders in early-stage translational research.

Methods and results: We conducted two literature searches in six databases, screened records and full-text articles, and abstracted and analyzed data from included publications. The literature searches yielded unduplicated 2,894 records. After screening, 13 articles were included.

Findings: Our review of the literature yielded rare reports of engagement in early-stage translational research. Half of included articles reported on engagement with patients, clinicians, and researchers while fewer that one in three reported on engagement with policymakers, industry, and insurers. One in four reported engagement in the publication's acknowledgments but not in the main text. More than half drew unmeasured conclusions about the outcomes of engagement.

Interpretation: Our definition of early-stage translation pointed to a specific set of peer-reviewed research; our findings indicate a reporting gap and not necessarily a gap in practice. By addressing four themes-developing a shared language, identifying frameworks and principles, creating a repository of resources, and establishing a research agenda, research leaders can develop new insights about how to engage communities in early-stage translational research.

早期翻译研究中利益相关者参与的综述。
背景:我们对同行评议文献进行了范围审查,以描述早期翻译研究中利益相关者参与报道的性质和程度。方法和结果:我们在6个数据库中进行了2次文献检索,筛选了记录和全文文章,并从纳入的出版物中提取和分析数据。文献检索得到了不重复的2894条记录。经筛选,纳入13篇文章。研究结果:我们对文献进行了回顾,发现很少有关于早期翻译研究的报道。纳入的文章中有一半报道了与患者、临床医生和研究人员的接触,而不到三分之一的文章报道了与政策制定者、行业和保险公司的接触。四分之一的人表示参与了出版物的致谢,但没有参与正文。超过一半的人对参与的结果得出了未经衡量的结论。解释:我们对早期翻译的定义指向一组特定的同行评议研究;我们的研究结果表明存在报告差距,而不一定是实践差距。通过解决四个主题——开发共享语言、确定框架和原则、创建资源库和建立研究议程,研究领导者可以就如何让社区参与早期翻译研究产生新的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical and Translational Science
Journal of Clinical and Translational Science MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.80
自引率
26.90%
发文量
437
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信